Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Carcinoma, Non-Small-Cell Lung 57Neoplasms 11Lung Neoplasms 11Small Cell Lung Carcinoma 8Thyroid Neoplasms 7Neoplasm Metastasis 6Head and Neck Neoplasms 6Carcinoma 6Breast Neoplasms 6Adenocarcinoma 6Colorectal Neoplasms 5Colonic Neoplasms 5Thyroid Diseases 4Thyroid Cancer, Papillary 4Thoracic Neoplasms 4Sarcoma 4Respiratory Tract Neoplasms 4Respiratory Tract Diseases 4Pancreatic Neoplasms 4Neuroendocrine Tumors 4Neoplasms by Site 4Melanoma 4Lung Diseases 4Endometrial Neoplasms 4Endocrine System Diseases 4Endocrine Gland Neoplasms 4Carcinoma, Renal Cell 4Carcinoma, Bronchogenic 4Bronchial Neoplasms 4Uterine Cervical Neoplasms 3

Interventions

ceritinib 1capmatinib 1Pemetrexed 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has announcements × Adenocarcinoma of Lung × Thoracic × Clear all
NCT01828099 2025-01-16

LDK378 Versus Chemotherapy in Previously Untreated Patients With ALK Rearranged Non-small Cell Lung Cancer

Novartis

Phase 3 Completed
376 enrolled 34 charts 1 FDA
Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02414139 2024-03-20

Study of Oral cMET Inhibitor INC280 in Patients With EGFR Wild-type (wt), Advanced Non-small Cell Lung Cancer (NSCLC) (Geometry Mono-1)

Novartis

Phase 2 Completed
373 enrolled 34 charts 2 FDA
Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡